Clinical Trials Browser

Phase 1/2 × Carcinoma, Renal Cell × Vorinostat × Clear all

NCT00324740 2021-02-23

Vorinostat and Isotretinoin in Treating Patients With Advanced Kidney Cancer

Phase 1/2 Terminated

14 enrolled 8 charts

Carcinoma, Renal Cell

NCT00324870 2016-01-13

Vorinostat and Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney Cancer

Phase 1/2 Completed

37 enrolled 6 charts

Carcinoma, Renal Cell